AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10545429
Drug: Conventional alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional alteplase (100 mg/180 min; n=15)
Trial: 6318350
Drug: Bi‐Profenid 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bi‐Profenid 150 mg (one 150 mg tablet twice daily for 2 days)
Trial: 6318350
Drug: Conventional forms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional forms (two 50 mg Profenid capsules each morning and noon with one 100 mg suppository each evening for 2 days)
Trial: 31835978
Drug: Platelet transfusion
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet transfusion during rewarming phase (10 mL/kg)
Trial: 24443618
Drug: trastuzumab-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trastuzumab-based chemotherapy
Trial: 17412737
Drug: Infliximab 3
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab 3 mg/kg at weeks 0, 2, 6, 14 and 22
Trial: 10963245
Drug: Self-management of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-management of oral anticoagulant therapy
Trial: 8640434
Drug: No intracameral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intracameral antibiotics (control group)
Trial: 1531090
Drug: Prednisolone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (40 mg per day for 28 days)
Trial: 6323525
Drug: Antibody to
RxNorm normalized name: Antibody to HPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibody to gD and vp66
Trial: 29239664
Drug: SR paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR paracetamol 2×1000 mg BID
Trial: 20116153
Drug: Dialysis dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysis dose
Trial: 11109233
Drug: Imagery-rehearsal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imagery-rehearsal therapy (treatment group)
Trial: 8845036
Drug: Oral vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vaccination with whole cell/B subunit (CTB) cholera vaccine
Trial: 8845036
Drug: Local intravaginal
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local intravaginal vaccination with whole cell/B subunit (CTB) cholera vaccine mixed with eldexomer gel
Trial: 1341234
Drug: Group B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B: approximately 3.0 g d‐1 sodium sulphate in juice
Trial: 1341234
Drug: Group C:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C: 30 g d‐1 supplementary dietary fibre as wheat bran in bread
Trial: 22891797
Drug: N-acetyl cysteine
RxNorm normalized name: N-Acetyl Cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl cysteine (NAC) 2 g/day as adjunct maintenance treatment
Trial: 20378080
Drug: Mipomersen 200
RxNorm normalized name: mipomersen 200 mg/mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen 200 mg/week
Trial: 21593041
Drug: Mipomersen 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen 300 mg/week
Trial: 17094172
Drug: Water extract
RxNorm normalized name: Panax ginseng root water extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water extract of Hibiscus sabdariffa (300 mL daily for 3 days)
Trial: 18598992
Drug: Conventional treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatments with distal colonoscopy
Trial: 18598992
Drug: Anti-viral treatment
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-viral treatment added to conventional treatments
Trial: 9362378
Drug: IL-2 treatment
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IL-2 treatment overall
Trial: 11915784
Drug: HIGH CHO
RxNorm normalized name: High choriolytic enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIGH CHO diet (greater than 70% of daily energy intake from CHO)
Trial: 11915784
Drug: LOW CHO
RxNorm normalized name: Low choriolytic enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LOW CHO diet (less than 10% of daily energy intake from CHO)
Trial: 21831359
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER (6 mg)
Trial: 22585590
Drug: Risperidone (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (3 mg)
Trial: 17376267
Drug: Rhubarb preventive
RxNorm normalized name: RHUBARB
DrugBank: Rhubarb (DB10651)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhubarb preventive treatment group (3.0%)
Trial: 17376267
Drug: Enteral combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral combined parenteral nutrition support subgroup (2.1%)
Trial: 17376267
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition support subgroup
Trial: 12030958
Drug: Double dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double dose of proton pump inhibitor
Trial: 12030958
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of proton pump inhibitor
Trial: 2189319
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of intranasal flunisolide (0.025% solution, 200 micrograms daily for 4 weeks)
Trial: 2189319
Drug: Original formulation
RxNorm normalized name: Zegerid (Original Formulation)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original formulation of intranasal flunisolide (0.025% solution, 200 micrograms daily for 4 weeks)
Trial: 2189319
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of intranasal flunisolide
Trial: 2189319
Drug: Original formulation
RxNorm normalized name: Zegerid (Original Formulation)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original formulation of intranasal flunisolide
Trial: 43164
Drug: Atenolol (138
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (138 +/- 13 mg daily)
Trial: 43164
Drug: Metoprolol (234
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (234 +/- 22 mg daily)
Trial: 43164
Drug: Pindolol (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (24 +/- 2 mg daily)
Trial: 43164
Drug: Labetalol (308
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (308 +/- 34 mg daily)
Trial: 30777131
Drug: High-dose Interleukin-2
RxNorm normalized name: Interleukin-2 aldesleukin
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose Interleukin-2 (HD IL-2)
Trial: 17432678
Drug: Shenfu Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu Injection (SF) 1 mL/kg
Trial: 17432678
Drug: Shenfu Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu Injection (SF)
Trial: 14571614
Drug: Luohuo Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luohuo Capsule (LHC)
Trial: 8804239
Drug: Subcutaneous (s.c.)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (s.c.) recombinant erythropoietin (rH-EPO)
Trial: 8804239
Drug: Intravenous (i.v.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (i.v.) recombinant erythropoietin (rH-EPO)
Trial: 6376918
Drug: Low-phosphorus, low-protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-phosphorus, low-protein diet (7.0 mg phosphorus and 0.5 g protein per kg body weight)
Trial: 6376918
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (12 mg phosphorus and 0.8 g protein per kg body weight)
Trial: 29573473
Drug: Romosozumab 210
RxNorm normalized name: ROMOSOZUMAB
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Romosozumab 210 mg s.c. once monthly for 12 months
Trial: 24774860
Drug: Calcitriol supplementation
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcitriol supplementation (0.5 μg/day for one year)
Trial: 17920715
Drug: Hyperfractionated radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiotherapy (HF) - 58 Gy in 40 equal fractions given twice per day
Trial: 17920715
Drug: Conventional fractionation
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fractionation (CF) - 51 Gy in 20 equal daily fractions
Trial: 16033855
Drug: Short daily
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short daily hemodialysis (6 sessions/wk of 3 h each)
Trial: 12241539
Drug: Noradrenaline infusion
RxNorm normalized name: noradrenaline hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noradrenaline infusion (0.147 nmol.min(‐1).kg(‐1))
Trial: 12241539
Drug: Emagel infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Emagel infusion (control)
Trial: 9737807
Drug: Troglitazone 400
RxNorm normalized name: troglitazone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 400 mg once daily
Trial: 9737807
Drug: Troglitazone 200
RxNorm normalized name: troglitazone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 200 mg twice daily
Trial: 9737807
Drug: Troglitazone 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 800 mg once daily
Trial: 9737807
Drug: Troglitazone 400
RxNorm normalized name: troglitazone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 400 mg twice daily
Trial: 25239484
Drug: 0.5 mL
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mL vaccine subcutaneously at days 0, 14
Trial: 25239484
Drug: 0.5 mL
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mL vaccine subcutaneously at days 0 and 28
Trial: 25239484
Drug: 0.5 mL
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mL vaccine subcutaneously at days 0, 14, and 28
Trial: 25239484
Drug: 0.25 mL
RxNorm normalized name: mineral oil 0.25 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mL vaccine subcutaneously at days 0, 14, and 28
Trial: 22348304
Drug: Diclofenac suppository
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac suppository (100 mg) plus saline 0.9% (placebo)
Trial: 22348304
Drug: Diclofenac suppository
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac suppository (100 mg) plus intravenous papaverine hydrochloride (1.5 mg/kg up to 120 mg)
Trial: 11896091
Drug: Soy beverage
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy beverage containing 90 mg of isoflavones
Trial: 9808483
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral clodronate (800 mg)
Trial: 9808483
Drug: Daily intranasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily intranasal calcitonin (200 IU)
Trial: 2521333
Drug: Furosemide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (5 mg i.v. bolus)
Trial: 7262760
Drug: Lidaprim (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidaprim (combination of sulfametrol and trimethoprim)
Trial: 30678256
Drug: Mother’s own
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mother’s own milk (MOM) supplements of preterm formula
Trial: 28914247
Drug: Nitrous oxide
RxNorm normalized name: Nitrous Oxide
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitrous oxide (N2O)‐oxygen (O2) inhalation sedation using preadjusted mix of 30% N2O and 70% O2 through rapid induction technique
Trial: 27128005
Drug: Extemporaneous preparation
RxNorm normalized name: Extemporaneous preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extemporaneous preparation suspension (EP; 10 mg/mL)
Trial: 27128005
Drug: Crushed sildenafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed sildenafil 20 mg tablet mixed with apple sauce
Trial: 27128005
Drug: Intact sildenafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intact sildenafil 20 mg tablet
Trial: 23628755
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy and exercise (MTEX)
Trial: 22480173
Drug: Resection of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resection of the primary tumour prior to systemic chemotherapy
Trial: 22480173
Drug: Systemic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic chemotherapy without resection of the primary tumour
Trial: 19365388
Drug: Cymbalta (antidepressant,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cymbalta (antidepressant, serotonin and noradrenalin reuptake inhibitor)
Trial: 17689883
Drug: Short-term androgen
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term androgen deprivation (STAD) + radiation therapy (RT)
Trial: 9581695
Drug: Thymosin alpha1
RxNorm normalized name: Thymosin alpha1 (human)
DrugBank: Thymalfasin (DB04900)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymosin alpha1 (Talpha) 1.6 mg subcutaneous injection two times a week for 26 weeks (T6 group)
Trial: 9581695
Drug: Thymosin alpha1
RxNorm normalized name: Thymosin alpha1 (human)
DrugBank: Thymalfasin (DB04900)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymosin alpha1 (Talpha) 1.6 mg subcutaneous injection two times a week for 52 weeks (T12 group)
Trial: 9581695
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (T0 group) followed up for 18 months without specific treatment
Trial: 8114857
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (1.3 or 0.58 g of protein per kg per day)
Trial: 8114857
Drug: Very-low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very-low-protein diet (0.28 g per kg per day)
Trial: 8114857
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (0.58 g per kg per day)
Trial: 3404450
Drug: Ultra-low yield
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-low yield cigarettes (0.1, 0.4, 0.7 mg nicotine)
Trial: 3404450
Drug: Usual-brand high-yield
RxNorm normalized name: Eagle Brand Medicated Oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual-brand high-yield cigarettes (1.0, 1.1 mg nicotine)
Trial: 28776320
Drug: New Medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New Medicine Service (NMS)
Trial: 26071796
Drug: Tigatuzumab (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tigatuzumab (6 mg/kg loading, 2 mg/kg/week maintenance) plus sorafenib 400 mg twice daily
Trial: 26071796
Drug: Tigatuzumab (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tigatuzumab (6 mg/kg loading, 6 mg/kg/week maintenance) plus sorafenib 400 mg twice daily
Trial: 23924691
Drug: Black soy
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black soy peptide supplementation (4.5 g daily for 8 weeks)
Trial: 21650086
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg ascorbic acid (Vit. C)
Trial: 19526424
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch (15 mg/16 h)
Trial: 19526424
Drug: Nasal spray
RxNorm normalized name: Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal spray (recommended regimen of 24 doses per day)
Trial: 16946104
Drug: R406 (spleen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R406 (spleen tyrosine kinase inhibitor)
Trial: 8933645
Drug: Erythritol (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythritol (0.3 g/kg on Day 1, 0.6 g/kg on Day 2, 1.0 g/kg on Days 3-7)
Trial: 1808616
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg every 4 hr for eight doses)
Trial: 1808616
Drug: Sustained-release theophylline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release theophylline tablets after ranitidine pretreatment
Trial: 1808616
Drug: Immediate-release tablets
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release tablets
Trial: 1808616
Drug: Sustained-release theophylline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release theophylline tablets
Trial: 6412583
Drug: Benzylpenicillin preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzylpenicillin preparation containing oil and alum monostearate
Trial: 6412583
Drug: Benzylpenicillin preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzylpenicillin preparation without oil and alum monostearate
Trial: 6412583
Drug: Benzylpenicillin preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzylpenicillin preparation without adjuvants initiated by benzylpenicillin preparation containing oil and alum monostearate
Trial: 31079567
Drug: Intravenous zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous zoledronic acid (5 mg in 100 ml) applied on the 5th day after ACDF surgery
Trial: 24740528
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of ketamine hydrochloride (0.5 mg/kg)
Trial: 20945946
Drug: Edaravone 30
RxNorm normalized name: edaravone 30 MG in 100 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edaravone 30 mg twice daily for 10-14 days (long-term group)
Trial: 20945946
Drug: Edaravone 30
RxNorm normalized name: edaravone 30 MG in 100 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edaravone 30 mg twice daily for 3 days (short-term group)
Trial: 18720535
Drug: Herbal formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal formulation (Curcuma longa and Tinospora cordifolia)
Trial: 15889523
Drug: TCM drugs
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TCM drugs
Trial: 10535343
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg mifepristone
Trial: 1816187
Drug: Intermittent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent infusion (10 mg/kg/6 h)
Trial: 1816187
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion (10 mg/kg/6 h)
Trial: 6355053
Drug: Acyclovir cream
RxNorm normalized name: Acyclovir Cream
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir cream for initial genital herpes
Trial: 6355053
Drug: Acyclovir cream
RxNorm normalized name: Acyclovir Cream
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir cream for recurrent genital herpes
Trial: 24916419
Drug: Test dental
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test dental gel
Trial: 24916419
Drug: Control dental
RxNorm normalized name: Dental Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control dental gel
Trial: 19461584
Drug: Cetilistat 80
RxNorm normalized name: Cetilistat
DrugBank: Cetilistat (DB06586)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Cetilistat 80 mg t.i.d.
Trial: 19461584
Drug: Cetilistat 40
RxNorm normalized name: Cetilistat
DrugBank: Cetilistat (DB06586)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Cetilistat 40 mg t.i.d.
Trial: 17425687
Drug: Standard doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard doses of enoxaparin (30 mg b.i.d. or 40 mg o.d.)
Trial: 8245337
Drug: Oral disopyramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral disopyramide (800 mg/day)
Trial: 8245337
Drug: No pharmacological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pharmacological treatment (control)
Trial: 3084442
Drug: 2% mupirocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% mupirocin ointment applied four times a day for five days
Trial: 2112167
Drug: 2% mupirocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% mupirocin ointment
Trial: 31678185
Drug: Host-associated probiotic
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Host-associated probiotic (HAP) Enterococcus faecium strain CGMCC1.2136, 108 CFU g-1
Trial: 31678185
Drug: Commercial probiotic
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial probiotic (CP) Pediococcus acidilactici, 107 CFU g-1